Acinetobacter baumannii has emerged in the last decades ... Other therapeutic options include sulbactam, aminoglycosides, polymixyns and tigecycline. The discovery of new therapies coupled with ...

Since tigecycline can be one of the rare treatment options in some multidrug-resistant Gram-negative bacteria (e.g. Acinetobacter baumannii), further studies with higher doses of tigecycline are ...

The clinical burden of carbapenem-resistant Acinetobacter baumannii has worsened across U.S. hospitals in recent years, according to a study published April 17 in BMC Infectious Diseases.

Named Acinetobacter baumannii (A. baumannii), this "dangerous" superbug is currently circulating through a hospital in Malaysia. It has the potential to cause blood, lung, or urinary tract ...